Log in
Enquire now
‌

US Patent 11478543 Coronavirus disease (COVID-19) vaccine

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Thomas Jefferson University
Thomas Jefferson University
Current Assignee
Thomas Jefferson University
Thomas Jefferson University
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11478543
Date of Patent
October 25, 2022
Patent Application Number
17193890
Date Filed
March 5, 2021
Patent Primary Examiner
‌
Barry A Chestnut
CPC Code
‌
C12N 2770/20034
‌
G01N 2333/165
‌
G01N 33/56983
‌
A61K 2300/00
‌
A61P 31/14

The present invention includes a vaccine comprising a SARS-CoV-2 spike protein (S) or portion thereof, and methods of use thereof.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11478543 Coronavirus disease (COVID-19) vaccine

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.